Headquartered in Washington DC, the intellectual property department at Jones Day is well-equipped to handle a range of IP-related licensing, transactional, and commercialization matters for fintech, life sciences, and AI innovations. Based in Silicon Valley, Ka-on Li co-chairs the IP transactions team and counsels clients across a broad range of industries on licensing, outsourcing, compliance, and research and development contracts. An Doan, also based in Silicon Valley, focuses on the commercialization of IP and leveraging IP rights for an array of technologies, including semiconductors, software, and artificial intelligence. In San Diego, Robert Latta specializes in domestic and cross-border IP transactions and high-stakes due diligence for bioinformatics and data-enabled technologies.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Sector knowledge
Testimonials
Collated independently by Legal 500 research team.
‘Very responsive, very comprehensive, highly knowledgeable.’
‘The Jones Day team knows the law and industry. We don't have to pay them to learn the law; they already know it. That makes their responses quicker and less expensive than their contemporaries. It is not unusual to have a response to a complex question within a day.’
‘Tom Briggs treats my client as his most important even though I know I am not. He responds almost immediately, and I have never had to wait for anything. We've dealt with tough adversaries, and Tom handles them calmly and in such a way that the right answer always results.’
‘Jones Day's patent licensing team is a true collaborator and gets to know the entire picture, long-term plan, and appetite for risk in order to provide sound legal advice that takes into account more than just legal risk for their client. ’
‘Warren Nachlis has a wealth of knowledge and deep expertise, his ability to quickly issue spot and make sure different sub-sections within lengthy, complex transactions are in the best interest of his client, assures that his clients are protected when negotiating license agreements and related transactions. Warren does a great job summarizing key legal issues to educate decision makers at the intersection of legal/business decision.'
Key clients
- AbbVie Inc.
- Altium Limited
- Astellas Pharma
- Celgene Corporation/BMS
- City of Hope
- Daiichi Sankyo Company, Limited
- Educational Testing Service
- Genomatica
- Incyte Corporation
- MGI Tech Co., Ltd.
- Rich Data Corporation (Australia) Pty Ltd
- The Riverside Company
Work highlights
Advised Inmagene Biopharmaceuticals on the granting of global rights pursuant to collaborations with multiple partners to develop, manufacture, and commercialize antibody therapeutic candidates.
Advised Shanghai Jemincare Pharmaceutical Co., Ltd. on an exclusive license granting RAPT Therapeutics worldwide rights (excluding China, Hong Kong, Macau, Taiwan) to develop and commercialize RPT904, a clinical-stage, half-life–extended anti-IgE monoclonal antibody (JYB1904).
Represented MGI and CGI, US subsidiaries of MGI Tech, in a license to Swiss Rockets granting rights outside Asia-Pacific and Greater China to research, develop, manufacture, and commercialize sequencing products using CoolMPS technology.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Ka-on Li
Other key lawyers
An Doan; Robert Latta